Product: CNGA3 gene therapy study
Categories:
Research into gene therapy for achromatopsia is being carried out at the Department of Ophthalmology at the University Hospital in Tübingen. After safety and efficacy were proven in phase 1, children are now being included for the first time in phase 2.
Note
The exhibitor is solely responsible for the content of the exhibitor presentation both on the organizer’s website and on the website of the respective exhibitor. The organizer assumes no responsibility or liability.